Sophal Exports 2.3 Tonnes of Medicines to Côte d’Ivoire

Algerian pharmaceutical company Sophal successfully exported a 2.3-tonne shipment of medicines to Côte d'Ivoire on Monday. This operation marks a significant development for the national pharmaceutical industry, underscoring the country's expanding export capabilities in the health sector. The Ministry of Pharmaceutical Industry confirmed the shipment, noting its adherence to approved technical and regulatory conditions.

The export operation reflects the ongoing development within Algeria's pharmaceutical industry, driven by increasing local production capacities and improvements in the quality of national products. This enhancement boosts the competitiveness of Algerian pharmaceuticals in foreign markets, reinforcing Algeria's standing as a regional hub for the pharmaceutical sector. A second shipment to Côte d'Ivoire is anticipated in the coming weeks.

Officials emphasized that the export was conducted while ensuring the continued supply of various medicines to the national market. This approach demonstrates a commitment to balancing the essential needs of Algerian patients with the strategic promotion of the nation's pharmaceutical exports, contributing to economic diversification and industrial growth.